An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants

NCT05827887 · clinicaltrials.gov ↗
COMPLETED
Status
226
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie